Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT

Blood

Volumn 120, Issue 14, 2012, Pages 2796-2806

  Warren, Edus H ^a,b   Zhang, Xinyi Cindy ^a   Li, Shuying ^a   Fan, Wenhong ^a   Storer, Barry E ^a   Chien, Jason W ^a,b   Boeckh, Michael J ^a,b   Zhao, Lue Ping ^a   Martin, Paul J ^a,b   Hansen, John A ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHROMOSOME 4Q; CHROMOSOME 6P; DISEASE SEVERITY; DONOR; GENE; GENE LOCUS; GENE PRODUCT; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; HUMAN GENOME; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE RECEPTOR GENE; UGT2B17 GENE;

EID: 84867303407     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-347286     Document Type: Review

References (110)

1. Thomas E, Storb R, Clift RA, et al. Bone-marrow transplantation (first of two parts). N Engl J Med. 1975;292(16):832-843.
2. Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975;292(17):895-902.
3. Bleakley M, Riddell SR. Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia. Immunol Cell Biol. 2011;89(3):396-407.
4. Bray RA, Hurley CK, Kamani NR, et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant. 2008;14(9 Suppl):45-53.
5. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987;329(6139):506-512. (Pubitemid 17131093)
6. Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993;364(6432):33-39. (Pubitemid 23233452)
7. de Verteuil D, Granados DP, Thibault P, Perreault C. Origin and plasticity of MHC I-associated self peptides. Autoimmun Rev. 2012;11(9):627-635.
8. Barber LD, Gillece-Castro B, Percival L, Li X, Clayberger C, Parham P. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol. 1995;5(2):179-190.
9. Lippolis JD, White FM, Marto JA, et al. Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol. 2002;169(9):5089-5097. (Pubitemid 35217178)
10. Weinschenk T, Gouttefangeas C, Schirle M, et al. Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res. 2002;62(20):5818-5827. (Pubitemid 35204741)
11. Macdonald WA, Purcell AW, Mifsud NA, et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med. 2003;198(5):679-691. (Pubitemid 37087768)
12. Kruger T, Schoor O, Lemmel C, et al. Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy. Cancer Immunol Immunother. 2005;54(9):826-836. (Pubitemid 40991325)
13. Suri A, Lovitch SB, Unanue ER. The wide diversity and complexity of peptides bound to class II MHC molecules. Curr Opin Immunol. 2006;18(1):70-77. (Pubitemid 43049651)
14. Mester G, Hoffmann V, Stevanovic S. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell Mol Life Sci. 2011;68(9):1521-1532.
15. den Haan JM, Meadows LM, Wang W, et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science. 1998;279(5353):1054-1057. (Pubitemid 28113311)
16. Kawase T, Akatsuka Y, Torikai H, et al. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood. 2007;110(3):1055-1063. (Pubitemid 47267448)
17. Broen K, Levenga H, Vos J, et al. A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR. PLoS One. 2011;6(6):e21699.
18. Brickner AG, Evans AM, Mito JK, et al. The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood. 2006;107(9):3779-3786.
19. de Rijke B, van Horssen-Zoetbrood A, Beekman JM, et al.Aframeshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J Clin Invest. 2005;115(12):3506-3516. (Pubitemid 43121838)
20. Dolstra H, Fredrix H, Maas F, et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med. 1999; 189(2):301-308. (Pubitemid 29063251)
21. Tykodi SS, Fujii N, Vigneron N, et al. C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients. Clin Cancer Res. 2008; 14(16):5260-5269.
22. Griffioen M, Honders MW, van der Meijden ED, et al. Identification of 4 novel HLA-B&z.ast;40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity. Haematologica. 2012;97(8):1196-1204.
23. Mommaas B, Kamp J, Drijfhout JW, et al. Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. J Immunol. 2002;169(6):3131-3136. (Pubitemid 35013158)
24. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996;334(5):281-285. (Pubitemid 26033083)
25. Tseng LH, Lin MT, Hansen JA, et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood. 1999;94(8):2911-2914. (Pubitemid 29477321)
26. Murata M, Emi N, Hirabayashi N, et al. No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients. Int J Hematol. 2000;72(3):371-375.
27. Gallardo D, Arostegui JI, Balas A, et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol. 2001;114(4):931-936. (Pubitemid 32953757)
28. Lin MT, Gooley T, Hansen JA, et al. Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood. 2001;98(10):3172-3173.
29. Nesci S, Buffi O, Iliescu A, Andreani M, Lucarelli G. Recipient mHag-HA1 disparity and a GVHD in thalassemic-transplanted patients. Bone Marrow Transplant. 2003;31(7):575-578. (Pubitemid 36546836)
30. Kotzampasaki EM, Spyropoulou-Vlachou MS, Kalofoutis C, Vrani V, Kalofoutis A, Stavropoulos-Giokas C. Minor histocompatibility antigen HA-1 and HPA-5 polymorphisms in HLA-identical related bone marrow transplantation. Transplant Proc. 2004;36(6):1735-1738. (Pubitemid 39200415)
31. Heinemann FM, Ferencik S, Ottinger HD, Beelen DW, Grosse-Wilde H. Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors. Transplantation. 2004;77(7):1103-1106. (Pubitemid 38508932)
32. Katagiri T, Shiobara S, Nakao S, et al. Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan. Bone Marrow Transplant. 2006;38(10):681-686. (Pubitemid 44669683)
33. Spellman S, Warden MB, Haagenson M, et al. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant. 2009; 15(7):856-863.
34. Mutis T, Brand R, Gallardo D, van Biezen A, Niederwieser D, Goulmy E. Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients. Leukemia. 2010;24(7):1388-1392.
35. Xue Y, Sun D, Daly A, et al. Adaptive evolution of UGT2B17 copy-number variation. Am J Hum Genet. 2008;83(3):337-346.
36. Murata M, Warren EH, Riddell SR. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med. 2003;197(10):1279-1289. (Pubitemid 36617774)
37. Terakura S, Murata M, Warren EH, et al. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A&z.ast;2902 and -B&z.ast;4403. Transplantation. 2007;83(9):1242-1248. (Pubitemid 46743687)
38. Kamei M, Nannya Y, Torikai H, et al. HapMap scanning of novel human minor histocompatibility antigens. Blood. 2009;113(21):5041-5048.
39. McCarroll SA, Bradner JE, Turpeinen H, et al. Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet. 2009;41(12):1341-1344.
40. Medawar PB, Russell PS. Adrenal homografts in mice, with special reference to immunological adrenalectomy. Immunology. 1958;1(1):1-12.
41. Head JR, Neaves WB, Billingham RE. Immune privilege in the testis. I. Basic parameters of allograft survival. Transplantation. 1983;36(4):423-431. (Pubitemid 14230932)
42. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 2003;423(6942):825-837. (Pubitemid 36781267)
43. Voogt PJ, Goulmy E, Fibbe WE, Veenhof WF, Brand A, Falkenburg JH. Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells. J Clin Invest. 1988;82(3):906-912.
44. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Alloimmunity to human H-Y. Lancet. 1976;2(7996):1206.
45. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Y-antigen killing by T cells of women is restricted by HLA. Nature. 1977;266(5602):544-545. (Pubitemid 8079243)
46. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigenspecific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med. 1999;5(7):839-842. (Pubitemid 29318622)
47. .Wang W, Meadows LR, den Haan JM, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science. 1995;269(5230):1588-1590.
48. Pierce RA, Field ED, den Haan JM, et al. Cutting edge: the HLA-A&z.ast;0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol. 1999;163(12):6360-6364.
49. .Warren EH, Gavin MA, Simpson E, et al. The human UTY gene encodes a novel HLA-B8- restricted H-Y antigen. J Immunol. 2000;164(5): 2807-2814. (Pubitemid 30115516)
50. Vogt MH, van den Muijsenberg JW, Goulmy E, et al. The DBY gene codes for an HLA-DQ5- restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood. 2002;99(8):3027-3032. (Pubitemid 34525395)
51. Spierings E, Vermeulen CJ, Vogt MH, et al. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet. 2003; 362(9384):610-615. (Pubitemid 37013301)
52. Torikai H, Akatsuka Y, Miyazaki M, et al. A novel HLA-A*3303- restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol. 2004;173(11):7046-7054. (Pubitemid 39541094)
53. Ofran Y, Kim HT, Brusic V, et al. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes. Clin Cancer Res. 2010;16(5):1642-1651.
54. Miklos DB, Kim HT, Zorn E, et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood. 2004; 103(1):353-359. (Pubitemid 38035116)
55. Miklos DB, Kim HT, Miller KH, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 2005;105(7):2973-2978. (Pubitemid 40446295)
56. Zorn E, Miklos DB, Floyd BH, et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med. 2004;199(8):1133-1142. (Pubitemid 38619909)
57. Porcheray F, Miklos DB, Floyd BH, et al. Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation. Transplantation. 2011;92(3):359-365.
58. Kawase T, Ord ND, Towlerton A, et al. Frequency and intensity of antibody responses to antigens encoded by KDM5D (SMCY) and other H-Y genes after allogeneic hematopoietic cell transplantation [abstract]. Blood (ASH Annual Meeting Abstracts). 2011;118(21):Abstract 4028.
59. Storb R, Prentice RL, Thomas ED. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. J Clin Invest. 1977;59(4):625-632. (Pubitemid 8073823)
60. Stern M, Passweg JR, Locasciulli A, et al. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation. 2006; 82(2):218-226. (Pubitemid 44126819)
61. Gratwohl A, Hermans J, Niederwieser D, van Biezen A, van Houwelingen HC, Apperley J. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J. 2001;2(6):363-370. (Pubitemid 34048659)
62. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001; 98(7):2043-2051.
63. Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood. 2004;103(1):347-352. (Pubitemid 38029959)
64. Loren AW, Bunin GR, Boudreau C, et al. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12(7):758-769. (Pubitemid 43899412)
65. Stern M, Brand R, de Witte T, et al. Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am J Transplant. 2008;8(10):2149-2157.
66. Stewart BL, Storer B, Storek J, et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood. 2004;104(12):3501-3506. (Pubitemid 39564419)
67. A haplotype map of the human genome. Nature. 2005;437(7063):1299-1320.
68. Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449(7164):851-861.
69. Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467(7311):52-58.
70. Amap of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061-1073.
71. Spaapen RM, Lokhorst HM, van den Oudenalder K, et al. Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis. J Exp Med. 2008;205(12):2863-2872.
72. .Warren EH, Fujii N, Akatsuka Y, et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. Blood. 2010;115(19):3869-3878.
73. Van Bergen CA, Rutten CE, Van Der Meijden ED, et al. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res. 2010;70(22):9073-9083.
74. Karakoc E, Alkan C, O'Roak BJ, et al. Detection of structural variants and indels within exome data. Nat Methods. 2012;9(2):176-178.
75. Martin PJ. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant. 1991;8(3):217-223.
76. Chien JW, Zhang XC, Fan W, et al. Evaluation of published single nucleotide polymorphisms associated with acute graft versus host disease. Blood. 2012;119(22):5311-5319.
77. Fleischhauer K, Shaw BE, Gooley T, et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol. 2012;13(4):366-374.
78. Horton R, Gibson R, Coggill P, et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics. 2008;60(1):1-18.
79. Morishima S, Ogawa S, Matsubara A, et al. Impact of highly conserved HLA haplotype on acute graft-versus-host disease. Blood. 2010;115(23):4664-4670.
80. Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med. 2007;4(1):e8.
81. Parmar S, Del Lima M, Zou Y, et al. Donor-recipient mismatches in MHC class I chainrelated gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood. 2009;114(14):2884-2887.
82. Anderson E, Grzywacz B, Wang H, et al. Limited role of MHC class I chain-related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation. Blood. 2009;114(21):4753-4754.
83. Fleischhauer K, Zino E, Mazzi B, et al. Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1&z.ast;0901. Blood. 2001; 98(4):1122-1126.
84. Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood. 2006;107(7):2984-2992.
85. Gaschet J, Lim A, Liem L, et al. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. J Clin Invest. 1996;98(1):100-107. (Pubitemid 26243825)
86. Gaschet J, Gallot G, Ibisch C, et al. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1&z.ast;1001 mismatch: involvement of different TCRBV subsets. Bone Marrow Transplant. 1998;22(4):385-392. (Pubitemid 28401080)
87. Rutten CE, van Luxemburg-Heijs SA, Griffioen M, et al. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia. Leukemia. 2008;22(7):1387-1394. (Pubitemid 352006083)
88. Ogawa S, Matsubara A, Onizuka M, et al. Exploration of the genetic basis of GVHD by genetic association studies. Biol Blood Marrow Transplant. 2009;15(1 Suppl):39-41.
89. Shaw BE, Gooley TA, Malkki M, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007;110(13): 4560-4566. (Pubitemid 351377824)
90. Kawase T, Matsuo K, Kashiwase K, et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood. 2009;113(12):2851-2858.
91. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood. 2004;103(4):1417-1424. (Pubitemid 38168657)
92. Zino E, Vago L, Di Terlizzi S, et al. Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2007;13(9):1031-1040. (Pubitemid 47215559)
93. Crocchiolo R, Zino E, Vago L, et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood. 2009; 114(7):1437-1444.
94. Sizzano F, Zito L, Crivello P, et al. Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities. Blood. 2010;116(11):1991-1992.
95. Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, et al. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro. Blood. 2010;115(1): 151-153.
96. Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, et al. HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles. Biol Blood Marrow Transplant. 2010;16(9):1282-1292.
97. Vie H, Gaschet J, Milpied N. Permissive, nonpermissive HLA-DPB1 epitope disparities and the specificity of T cells infiltrating the skin during acute graft-versus-host disease. Blood. 2011; 117(21):5779-5781.
98. De Libero G, Casorati G, Giachino C, et al. Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med. 1991; 173(6):1311-1322.
99. Sherwood AM, Desmarais C, Livingston RJ, et al. Deep sequencing of the human TCRgamma and TCRbeta repertoires suggests that TCRbeta rearranges after alphabeta and gammadelta T cell commitment. Sci Transl Med. 2011;3(90):90ra61.
100. Spada FM, Grant EP, Peters PJ, et al. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med. 2000;191(6):937-948.
101. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science. 1998; 279(5357):1737-1740. (Pubitemid 28164472)
102. Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol. 2001;2(5):443-451. (Pubitemid 33706143)
103. Cooley S, Trachtenberg E, Bergemann TL, et al. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood. 2009;113(3):726-732.
104. Cooley S, Weisdorf DJ, Guethlein LA, et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010;116(14):2411-2419.
105. Stringaris K, Adams S, Uribe M, et al. Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies. Biol Blood Marrow Transplant. 2010;16(9):1257-1264.
106. Venstrom JM, Gooley TA, Spellman S, et al. Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood. 2010;115(15):3162-3165.
107. Nicholls S, Piper KP, Mohammed F, et al. Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition. Proc Natl Acad Sci U S A. 2009;106(10):3889-3894.
108. Hennecke J, Wiley DC. Structure of a complex of the human alpha/beta T-cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA&z.ast;0101 and DRB1&z.ast;0401): insight into TCR cross-restriction and alloreactivity. J Exp Med. 2002;195(5):571-581. (Pubitemid 34461502)
109. The PyMOL Molecular Graphics System, Version 1.5.0.1. Schrödinger, LLC.
110. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet. 2006;38(10):1166-1172. (Pubitemid 44470362)